SUDEEP PHARMA LIMITED (SUDEEPPHRM)

NSE: ₹758.60
BSE: ₹757.15
Stock Performance
Corporate Announcements
No recent announcements available.

Quarterly Financials

Consolidated Standalone
Particulars Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 87.88 90.28 80.17
YOY Revenue Growth % - - -
Other Income 12.83 9.44 9.62
Total Income 100.71 99.72 89.79
Total Expenses + 60.81 63.10 55.04
Cost of Materials Consumed 44.41 41.73 37.86
Employee Benefit Expense 7.42 8.15 5.99
Other Expenses 16.52 21.65 24.32
Operating Profit 27.08 27.19 25.12
OPM % 30.8% 30.1% 31.3%
Profit Before Tax + 39.90 36.62 34.74
Tax Expense 10.16 9.76 8.98
Tax % 25.5% 26.6% 25.8%
Profit After Tax 29.74 26.87 25.77
EPS (Basic) 2.67 2.42 2.31

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026
Revenue from Operations 338.51
YOY Revenue Growth % -
Other Income 38.50
Total Income 377.01
Total Expenses + 231.91
Cost of Materials Consumed 156.84
Employee Benefit Expense 28.95
Other Expenses 78.45
Operating Profit 106.59
OPM % 31.5%
Profit Before Exceptional 145.10
Exceptional Items 0.00
Profit Before Tax + 145.10
Tax Expense 37.52
Tax % 25.9%
Profit After Tax 107.58
EPS (Basic) 9.65

Balance Sheet

Particulars Mar 2026
ASSETS
Non-Current Assets + 515.83
Property, Plant & Equipment 90.27
Capital Work in Progress 157.84
Non-Current Investments 32.07
Goodwill 0.00
Other Intangible Assets 0.19
Current Assets + 457.95
Inventories 130.77
Trade Receivables 80.13
Cash and Cash Equivalents 2.18
Current Investments 0.00
LIABILITIES & EQUITY
Total Equity 786.01
Equity Share Capital 11.29
Other Equity 774.71
Non-Current Liabilities 42.70
Current Liabilities 145.07
Total Liabilities 187.77

Cash Flow Statement

Particulars Mar 2026
Cash from Operating Activities 96.02
Cash from Investing Activities -366.68
Cash from Financing Activities 242.50
Net Increase/Decrease in Cash -28.16